{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T14:22:26Z","timestamp":1725632546885},"reference-count":47,"publisher":"Impact Journals, LLC","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2021,2,15]]},"DOI":"10.18632\/aging.202364","type":"journal-article","created":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T12:55:35Z","timestamp":1610283335000},"page":"3957-3968","source":"Crossref","is-referenced-by-count":5,"title":["Gene signatures of 6-methyladenine regulators in women with lung adenocarcinoma and development of a risk scoring system: a retrospective study using the cancer genome atlas database"],"prefix":"10.18632","volume":"13","author":[{"given":"Chundi","family":"Gao","sequence":"first","affiliation":[{"name":"College of First Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan 250014, Shandong, PR China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhuang","sequence":"additional","affiliation":[{"name":"Departmen of Oncology, Weifang Traditional Chinese Hospital, Weifang 261041, Shandong, PR China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huayao","family":"Li","sequence":"additional","affiliation":[{"name":"College of Basic Medical Sciences, Shandong University of Traditional Chinese Medicine, Jinan 250014, Shandong, PR China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cun","family":"Liu","sequence":"additional","affiliation":[{"name":"College of First Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan 250014, Shandong, PR China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Zhou","sequence":"additional","affiliation":[{"name":"Departmen of Oncology, Weifang Traditional Chinese Hospital, Weifang 261041, Shandong, PR China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijuan","family":"Liu","sequence":"additional","affiliation":[{"name":"Departmen of Oncology, Weifang Traditional Chinese Hospital, Weifang 261041, Shandong, PR China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fubin","family":"Feng","sequence":"additional","affiliation":[{"name":"Departmen of Oncology, Weifang Traditional Chinese Hospital, Weifang 261041, Shandong, PR China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changgang","family":"Sun","sequence":"additional","affiliation":[{"name":"Departmen of Oncology, Weifang Traditional Chinese Hospital, Weifang 261041, Shandong, PR China"},{"name":"Cancer and Immunology Institute, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, PR China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2021,1,10]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"6","author":"Jemal","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"2","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature12213","article-title":"Mutational heterogeneity in cancer and the search for new cancer-associated genes.","volume":"49","author":"McKenna","year":"2013","journal-title":"Nature"},{"key":"3","doi-asserted-by":"publisher","first-page":"777","DOI":"10.4143\/crt.2018.387","article-title":"A phase II trial of osimertinib in the second-line treatment of non-small cell lung cancer with the EGFR T790M mutation, detected from circulating tumor DNA: LiquidLung-O-cohort 2.","volume":"5","author":"Kim","year":"2019","journal-title":"Cancer Res Treat"},{"key":"4","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1001\/jamaoncol.2018.3676","article-title":"Hyperprogressive disease in patients with advanced non-small cell lung cancer treated with PD-1\/PD-L1 inhibitors or with single-agent chemotherapy.","volume":"4","author":"Lefebvre","year":"2018","journal-title":"JAMA Oncol"},{"key":"5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/978-94-017-7215-0_5","article-title":"The role of epigenomics in the study of cancer biomarkers and in the development of diagnostic tools.","volume":"86","author":"Verma","year":"2015","journal-title":"Adv Exp Med Biol"},{"key":"6","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1161\/CIRCRESAHA.118.310998","article-title":"Epigenomics: technologies and applications.","volume":"12","author":"Chang","year":"2018","journal-title":"Circ Res"},{"key":"7","doi-asserted-by":"publisher","first-page":"D195","DOI":"10.1093\/nar\/gkq1028","article-title":"The RNA modification database, RNAMDB: 2011 update.","volume":"3","author":"Agris","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"8","doi-asserted-by":"publisher","first-page":"64527","DOI":"10.18632\/oncotarget.11743","article-title":"Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells.","volume":"7","author":"Semenza","year":"2016","journal-title":"Oncotarget"},{"key":"9","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1038\/leu.2014.16","article-title":"WTAP is a novel oncogenic protein in acute myeloid leukemia.","volume":"2","author":"Rao","year":"2014","journal-title":"Leukemia"},{"key":"10","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1002\/hep.29683","article-title":"RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.","volume":"6","author":"Wong","year":"2018","journal-title":"Hepatology"},{"key":"11","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.bbrc.2016.11.077","article-title":"MiR-33a suppresses proliferation of NSCLC cells via targeting METTL3 mRNA.","volume":"48","author":"Gao","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbaa225","article-title":"Molecular characterization, biological function, tumor microenvironment association and clinical significance of m6A regulators in lung adenocarcinoma.","author":"Lu","year":"2020","journal-title":"Brief Bioinform"},{"key":"13","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nrg3539","article-title":"Emerging patterns of somatic mutations in cancer.","volume":"1","author":"Chin","year":"2013","journal-title":"Nat Rev Genet"},{"key":"14","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/nature05329","article-title":"Global variation in copy number in the human genome.","volume":"44","author":"Freeman","year":"2006","journal-title":"Nature"},{"key":"15","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature17676","article-title":"Landscape of somatic mutations in 560 breast cancer whole-genome sequences.","volume":"53","author":"Smid","year":"2016","journal-title":"Nature"},{"key":"16","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1200\/JCO.2017.74.7576","article-title":"Osimertinib as first-line treatment of EGFR mutation-positive advanced non-small-cell lung cancer.","volume":"3","author":"Markovets","year":"2018","journal-title":"J Clin Oncol"},{"key":"17","doi-asserted-by":"publisher","first-page":"e88300","DOI":"10.1371\/journal.pone.0088300","article-title":"Classification of non-small cell lung cancer based on copy number alterations.","volume":"9","author":"Cai","year":"2014","journal-title":"PLoS One"},{"key":"18","doi-asserted-by":"publisher","first-page":"djw200","DOI":"10.1093\/jnci\/djw200","article-title":"Development of a RNA-seq based prognostic signature in lung adenocarcinoma.","volume":"10","author":"Chinnaiyan","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"19","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.7150\/ijbs.39046","article-title":"Diagnostic, progressive and prognostic performance of mA methylation RNA regulators in lung adenocarcinoma.","volume":"1","author":"Jin","year":"2020","journal-title":"Int J Biol Sci"},{"key":"20","doi-asserted-by":"publisher","first-page":"e919644","DOI":"10.12659\/MSM.919644","article-title":"Expression and prognostic significance of m6A-related genes in lung adenocarcinoma.","volume":"2","author":"Sun","year":"2020","journal-title":"Med Sci Monit"},{"key":"21","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3389\/fonc.2020.00208","article-title":"Malignant evaluation and clinical prognostic values of m6A RNA methylation regulators in glioblastoma.","volume":"1","author":"Chen","year":"2020","journal-title":"Front Oncol"},{"key":"22","doi-asserted-by":"publisher","first-page":"768","DOI":"10.3389\/fonc.2020.00768","article-title":"Exploration of potential roles of m6A regulators in colorectal cancer prognosis.","volume":"1","author":"Zhang","year":"2020","journal-title":"Front Oncol"},{"key":"23","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.3390\/cancers11101472","article-title":"Current Perspectives in Cancer Immunotherapy.","volume":"1","author":"Zaravinos","year":"2019","journal-title":"Cancers (Basel)"},{"key":"24","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00109-020-01908-9","article-title":"Immune landscape and a novel immunotherapy-related gene signature associated with clinical outcome in early-stage lung adenocarcinoma.","volume":"9","author":"Wang","year":"2020","journal-title":"J Mol Med (Berl)"},{"key":"25","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3892\/ijo.2020.5088","article-title":"Cutaneous melanoma and the immunotherapy revolution (review).","volume":"5","author":"Libra","year":"2020","journal-title":"Int J Oncol"},{"key":"26","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.3389\/fphar.2018.01300","article-title":"Evolution of cancer pharmacological treatments at the turn of the third millennium.","volume":"9","author":"Libra","year":"2018","journal-title":"Front Pharmacol"},{"key":"27","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.cell.2012.08.029","article-title":"Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing.","volume":"15","author":"Lawrence","year":"2012","journal-title":"Cell"},{"key":"28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics, 2018.","volume":"6","author":"Jemal","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"29","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1210\/er.2018-00160","article-title":"Genetics and epigenetics of gastroenteropancreatic neuroendocrine neoplasms.","volume":"4","author":"Scarpa","year":"2019","journal-title":"Endocr Rev"},{"key":"30","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1158\/2159-8290.CD-16-0745","article-title":"Emergence of the noncoding cancer genome: a target of genetic and epigenetic alterations.","volume":"6","author":"Lupien","year":"2016","journal-title":"Cancer Discov"},{"key":"31","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1158\/0008-5472.CAN-15-3278","article-title":"DNA methylation in cancer and aging.","volume":"7","author":"Cedar","year":"2016","journal-title":"Cancer Res"},{"key":"32","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1093\/carcin\/bgv146","article-title":"Aberrant DNA methylation in non-small cell lung cancer-associated fibroblasts.","volume":"3","author":"Moran","year":"2015","journal-title":"Carcinogenesis"},{"key":"33","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/nchembio.687","article-title":"N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO.","volume":"7","author":"He","year":"2011","journal-title":"Nat Chem Biol"},{"key":"34","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nrm3785","article-title":"The dynamic epitranscriptome: N6-methyladenosine and gene expression control.","volume":"1","author":"Jaffrey","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"35","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1038\/s41467-019-09865-9","article-title":"RNA mA methylation regulates the epithelial mesenchymal transition of cancer cells and translation of snail.","volume":"1","author":"Wang","year":"2019","journal-title":"Nat Commun"},{"key":"36","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13045-020-00895-1","article-title":"Emerging role of RNA methyltransferase METTL3 in gastrointestinal cancer.","volume":"1","author":"Wang","year":"2020","journal-title":"J Hematol Oncol"},{"key":"37","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12943-019-1066-3","article-title":"Molecular characterization and clinical relevance of mA regulators across 33 cancer types.","volume":"1","author":"Xu","year":"2019","journal-title":"Mol Cancer"},{"key":"38","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1128\/mcb.14.1.518","article-title":"The C-protein tetramer binds 230 to 240 nucleotides of pre-mRNA and nucleates the assembly of 40S heterogeneous nuclear ribonucleoprotein particles.","volume":"1","author":"LeStourgeon","year":"1994","journal-title":"Mol Cell Biol"},{"key":"39","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/nature14234","article-title":"N(6)-methyladenosine-dependent RNA structural switches regulate RNA-protein interactions.","volume":"51","author":"Pan","year":"2015","journal-title":"Nature"},{"key":"40","doi-asserted-by":"publisher","first-page":"11667","DOI":"10.18632\/aging.103333","article-title":"M6A-related bioinformatics analysis reveals that HNRNPC facilitates progression of OSCC via EMT.","volume":"1","author":"Lv","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"41","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-0916-x","article-title":"Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells.","volume":"56","author":"Weichselbaum","year":"2019","journal-title":"Nature"},{"key":"42","doi-asserted-by":"publisher","first-page":"4892","DOI":"10.1038\/s41467-019-12801-6","article-title":"YTHDF1 links hypoxia adaptation and non-small cell lung cancer progression.","volume":"1","author":"Zhou","year":"2019","journal-title":"Nat Commun"},{"key":"43","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1007\/s00018-008-8532-1","article-title":"Nuclear functions of heterogeneous nuclear ribonucleoproteins A\/B.","volume":"6","author":"Smith","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"44","doi-asserted-by":"publisher","first-page":"993","DOI":"10.26355\/eurrev_201802_14381","article-title":"Long non-coding RNA CACNA1G-AS1 promotes cell migration, invasion and epithelial-mesenchymal transition by HNRNPA2B1 in non-small cell lung cancer.","volume":"2","author":"Wang","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"45","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12943-019-1038-7","article-title":"METTL3 facilitates tumor progression via an mA-IGF2BP2-dependent mechanism in colorectal carcinoma.","volume":"1","author":"Kang","year":"2019","journal-title":"Mol Cancer"},{"key":"46","doi-asserted-by":"publisher","first-page":"4263","DOI":"10.26355\/eurrev_202004_21006","article-title":"Simvastatin is beneficial to lung cancer progression by inducing METTL3-induced m6A modification on EZH2 mRNA.","volume":"2","author":"Wang","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"47","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.2147\/OTT.S231914","article-title":"FTO facilitates lung adenocarcinoma cell progression by activating cell migration through mRNA demethylation.","volume":"1","author":"Jiang","year":"2020","journal-title":"Onco Targets Ther"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.202364","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T16:13:03Z","timestamp":1617725583000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.202364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,10]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,2,15]]}},"alternative-id":["202364","33428597"],"URL":"https:\/\/doi.org\/10.18632\/aging.202364","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,10]]}}}